Item 7.01 Regulation FD Disclosure

On January 13, 2020, Todd Smith, President and Chief Executive Officer of Zyla Life Sciences (the "Company"), will be using the presentation furnished as Exhibit 99.1 hereto at the J.P. Morgan Healthcare Conference.

The information set forth this Item 7.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 - Financial Statements and Exhibits





(d) Exhibits



Exhibit Number                    Description
  99.1             Zyla Life Sciences Investor Presentation.

© Edgar Online, source Glimpses